Abstract:Lung cancer is a malignancy with high incidence and mortality rates globally, and it has a 5-year survival rate of only 10%–20%. The significant heterogeneity in clinical presentation, histological features, multi-omics findings, and drug sensitivity among different lung cancer patients necessitate the development of personalized treatment strategies. The current precision medicine for lung cancer, primarily based on pathological and genomic multi-omics testing, fails to meet the needs of patients with clinically refractory lung cancer. Lung cancer organoids (LCOs) are derived from tumor cells within tumor tissues and are generated through three-dimensional tissue culture, enabling them to faithfully recapitulate in vivo tumor characteristics and heterogeneity. The establishment of a series of LCOs biobanks offers promising platforms for efficient screening and identification of novel targets for anti-tumor drug discovery. Moreover, LCOs provide supplementary decision-making factors to enhance the current precision medicine for lung cancer, thereby addressing the limitations associated with pathology-guided approaches in managing refractory lung cancer. This article presents a comprehensive review on the construction methods and potential applications of LCOs in both preclinical and clinical research. It highlights the significance of LCOs in biomarker exploration, drug resistance investigation, target identification, clinical precision drug screening, as well as microfluidic technology-based high-throughput drug screening strategies. Additionally, it discusses the current limitations and future prospects of this field.

Lung organoids, useful tools for investigating epithelial repair after lung injury

Lung Organoids—The Ultimate Tool to Dissect Pulmonary Diseases?

Human lung organoid: Models for respiratory biology and diseases

Alveolar Organoids in Lung Disease Modeling

Lung organoids: current uses and future promise

Recent advances in lung organoid development and applications in disease modeling

Lung Organoids and Their Use To Study Cell-Cell Interaction

Lung Organoids: Systematic Review of Recent Advancements and its Future Perspectives

Human Lung Organoids—A Novel Experimental and Precision Medicine Approach

Open questions in human lung organoid research

Organoids As a Powerful Model for Respiratory Diseases

Advanced lung organoids for respiratory system and pulmonary disease modeling

Organoids in Lung Cancer Management

Organoids in lung cancer: A teenager with infinite growth potential

Lung regeneration: diverse cell types and the therapeutic potential

Organogenesis of adult lung in a dish: Differentiation, disease and therapy

Lung Organoids as Model to Study SARS-CoV-2 Infection

Applications of lung cancer organoids in precision medicine: from bench to bedside

Lung cancer organoids: models for preclinical research and precision medicine

Human Lung Adenocarcinoma-Derived Organoid Models for Drug Screening

Use of three-dimensional organoids and lung-on-a-chip methods to study lung development, regeneration and disease